Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZAYO
651
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $48.7M | 0.03% |
1,406,784
-6,656
| -0.5% | -$228K |
|
|
DISCK
652
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $48.7M | 0.03% |
1,596,148
-39,939
| -2% | -$1.12M |
|
653
BioMarin Pharmaceuticals
BMRN
$13.3B
| $48.7M | 0.03% |
575,570
+84,123
| +17% | +$6.35M |
|
|
CTLT
654
DELISTED
CATALENT, INC.
CTLT
| $48.7M | 0.03% |
864,271
+4,294
| +0.5% | +$219K |
|
655
Marvell Technology
MRVL
$192B
| $48.6M | 0.03% |
1,830,027
+12,961
| +0.7% | +$328K |
|
656
First American
FAF
$7.37B
| $48.5M | 0.03% |
831,779
+15,889
| +2% | +$971K |
|
657
Primerica
PRI
$9.71B
| $48.3M | 0.03% |
370,197
-218
| -0.1% | -$28.2K |
|
658
Silicon Laboratories
SLAB
$7.2B
| $48.2M | 0.03% |
415,853
+4,110
| +1% | +$451K |
|
659
Crown Holdings
CCK
$13B
| $48.1M | 0.03% |
663,678
+7,375
| +1% | +$526K |
|
660
Blackstone Mortgage Trust
BXMT
$2.37B
| $48M | 0.03% |
1,290,297
+64,749
| +5% | +$2.36M |
|
661
Perrigo
PRGO
$1.74B
| $47.7M | 0.03% |
922,872
+32,784
| +4% | +$1.71M |
|
662
Hawaiian Electric Industries
HE
$2.03B
| $47.7M | 0.03% |
1,016,982
+18,872
| +2% | +$846K |
|
663
Neurocrine Biosciences
NBIX
$16.7B
| $47.5M | 0.03% |
441,477
+8,420
| +2% | +$882K |
|
664
Chemed
CHE
$7.23B
| $47.4M | 0.03% |
107,892
+5,904
| +6% | +$2.48M |
|
665
Euronet Worldwide
EEFT
$2.64B
| $47.4M | 0.03% |
300,601
+50
| +0% | +$7.55K |
|
666
Jones Lang LaSalle
JLL
$16.4B
| $47.1M | 0.03% |
270,622
+4,563
| +2% | +$718K |
|
667
Darling Ingredients
DAR
$10B
| $47M | 0.03% |
1,674,104
+6,635
| +0.4% | +$148K |
|
668
Bio-Rad Laboratories Class A
BIO
$9.44B
| $46.7M | 0.03% |
126,182
+673
| +0.5% | +$237K |
|
|
XHR
669
Xenia Hotels & Resorts
XHR
$1.73B
| $46.6M | 0.03% |
2,155,212
+52,758
| +3% | +$1.11M |
|
670
AGNC Investment
AGNC
$12.7B
| $46.5M | 0.03% |
2,629,540
+16,680
| +0.6% | +$284K |
|
671
Rithm Capital
RITM
$5.61B
| $46.4M | 0.02% |
2,880,086
+69,816
| +2% | +$1.1M |
|
672
Voya Financial
VOYA
$9.21B
| $46.3M | 0.02% |
758,496
-13,284
| -2% | -$750K |
|
673
ManpowerGroup
MAN
$2.61B
| $46.2M | 0.02% |
475,468
+76,856
| +19% | +$7.04M |
|
674
Southwest Gas
SWX
$6.57B
| $46.1M | 0.02% |
606,928
+14,251
| +2% | +$1.16M |
|
675
Cirrus Logic
CRUS
$6.15B
| $46.1M | 0.02% |
559,417
-5,523
| -1% | -$374K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.